



Normal pressure hydrocephalus:  
a qualitative study on outcome 
Hidrocefalia de pressão normal: história natural e prognóstico após cirurgia
Paulo Bugalho1,2, Luísa Alves1,2, Olga Ribeiro1
1Neurology Department, Hospital de Egas Moniz (CHLO), Centro de Estudos de Doenças Crónicas (CEDOC), NOVA Medical School, Universidade Nova de 
Lisboa, Lisboa, Portugal;
2Neurology Department, Faculdade de Ciências Médicas da Universidade Nova de Lisboa, Centro de Estudos de Doenças Crónicas (CEDOC), NOVA Medical 
School, Universidade Nova de Lisboa, Lisboa, Portugal.
Correspondence: Paulo Bugalho; Neurology Department; Hospital de Egas Moniz (CHLO); Rua da Junqueira 126; 1349-019 Lisboa - Portugal; E-mail: paulobugalho@sapo.pt
Conflict of interest: There is no conflict of interest to declare.
Received 04 November 2012; Received in final form 21 June 2013; Accepted 28 June 2013.
AbsTRACT
Objective: To describe the natural history and shunt outcome in patients with normal pressure hydrocephalus (NPH) and the variables that 
influence both. Method: Motor and cognitive parameters of 35 patients with NPH, as well as shunt surgery status, were registered at two 
time points (T0 and T1). Results: Thirteen patients underwent shunt surgery. Favorable outcome in gait function occurred in 5 of 35 patients 
and was related to younger age, absence of cardiovascular risk factors (CVRF) and white matter lesions (WML), and shunt surgery. Cognitive 
outcome was favorable in 9 of 35 patients and associated with shunt surgery (trend level). Of the patients subjected to surgery, favorable 
outcome in motor function was related to younger age at T0 and absence of CVRF and WML (trend level). Conclusion: Shunt surgery had a sig-
nificant effect on gait and less on cognition. Favorable outcome in gait was also associated with younger age and absence of CVRF and WML. 
 Keywords: normal pressure hydrocephalus, natural history, shunt surgery.
REsumo:
Objetivo: Descrever a história natural e o prognóstico após cirurgia de derivação ventricular em doentes com hidrocefalia de pressão normal 
(HPN), e as variáveis que potencialmente os influenciam. Método: Foram registados os parâmetros motores e cognitivos de 35 doentes com 
HPN, assim como o status relativo a cirurgia, em dois pontos no tempo (T0 e T1). Resultados: Treze doentes foram submetidos a cirurgia. 
Melhoria na marcha ocorreu em 5 doentes e relacionou-se com idade mais jovem, ausência de factores de risco cardio-vascular (FRCV), au-
sência de lesões da substância branca (LSB) e colocação de derivação ventricular. Verificou-se melhoria cognitiva em 9 doentes, associada 
(p=0,05) com colocação de derivação ventricular. Em doentes submetidos a cirurgia, o prognóstico favorável a nível motor relacionou-se com 
idade mais jovem em T0, ausência de FRCV e de LSB. Conclusão: A cirurgia para colocação de derivação ventricular teve um efeito significa-
tivo sobre a marcha e menor na cognição. O prognóstico favorável na marcha parece também associar-se a idade mais jovem, a ausência de 
FRV e de LSB.
Palavras-chave: hidrocefalia de pressão normal, história natural, cirurgia de derivação ventriculo-peritoneal.
Normal pressure hydrocephalus (NPH) was first des­
cri bed by Hakim and Adams as a syndrome that consisted 
of the triad of gait dysfunction, dementia, and urinary in­
continence, was associated with ventricular dilation, was 
potentially treatable by cerebrospinal fluid (CSF) surgical 
derivation (shunt surgery)1. Enthusiasm for shunt surgery de­
creased, however, as further studies revealed complications 
of the surgical procedure and lack of improvement in many 
cases. This prompted an extensive search for tests that could 
predict response to shunt surgery and for clinical and ima­
giological prognostic factors. Some authors have differen­
tia ted between the prognostic and diagnostic value of ancil­
lary tests, proposing that diagnosis should be based solely on 
clinical criteria (negative response to shunt surgery or nega­
tive results in tests that predict shunt response should not ex­
clude NPH diagnosis, as brain changes in many patients may 
already be irreversible)2. Investigative approaches have varied 
from clinically based studies3 to technically demanding pro­
cedures such as intracranial pressure (ICP) monitoring and 
determination of CSF outflow resistance (CSFRo). Results as­
sessing the ability of the CSFRo value to predict response to 
shunt surgery have varied from study to study, and thresholds 
seem to depend on the protocol used by each center4,5. ICP 
monitoring and CSFRo are also time and money consuming 
and more invasive than other procedures. Measures of out­
come after shunt surgery have also varied widely from study 
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to study; these include semi­quantitative global scales and 
more specific measures of cognitive and gait dysfunction, 
which are seldom accessible in most clinical environments, 
leading some to defend more clinically driven bedside ap­
proaches, particularly in relation to gait6. The natural his­
tory of NPH is relatively unexplored because investigations 
have mainly been driven by the need to find suitable candi­
dates for shunt surgery. Information about the natural his­
tory could be valuable for planning the follow­up of patients 
for whom surgical treatment is not indicated or who refuse 
intervention when proposed. 
In this study, our objectives were to describe the natural 
history and shunt outcome of a cohort of idiopathic NPH pa­




Inclusion criteria were clinically based and followed pro­
posed guidelines for probable NPH7: 1. symmetrical, slowly 
progressive gait dysfunction with insidious onset; 2. at least 
one other symptom of the triad (urinary incontinence not ex­
plained by urologic conditions, cognitive decline); 3. insidious 
onset of symptoms after 40 years of age; 4. non­obstructive 
hydrocephalus (Evan’s index >0.3) with obliteration of the ce­
rebral sulci; 5. normal CSF pressure at lumbar puncture (LP) 
(70–245 mm H2O); 6. exclusion of other causes.
description of procedures undertaken
To guide therapeutic decisions, patients underwent a 
study protocol designed to predict response to shunt surgery. 
Decisions were based on the conjoined input of the neurolo­
gist, patient, and family members after discussion of the risks 
and benefits in each individual case. Decisions were thus tai­
lored to each situation and not guided by homogenous gui­
delines. Some patients did not perform some of the tests 
(specified below). 
study protocol
Patient outcome was assessed by cognitive and gait dys­
function at two different time points (T0 and T1). Time bet­
ween assessments varied from patient to patient, but was 
always greater than 1 year (range: 1 to 9 years). We also regis­
tered the symptoms of the triad, first symptom of the triad, 
age at study inclusion, age of onset, duration of symptoms, 
and time from T0 to T1. A mini­Mental State Examination 
(MMSE)8 score at T0 was available for 31 patients (cogni­
tive dysfunction defined according to cut­off scores of the 
Portuguese version of the test9). 
Thirty­one patients were evaluated by a 10­m timed wal­
king test, with assessment of gait velocity, stride length, and 
stride duration. Postural responses were tested by a shoulder 
tug test, which assesses the patient’s postural res ponses to a 
backward tug on the shoulders10. The tests were performed 
in our department’s in­patient clinic in standardi zed condi­
tions at admission, before and 12, 24, 48, and 72 h after high 
volume (40 ml) LP. Variation percentages were calculated for 
each of the four variables, according to the following formu­
la: [(result before LP–best result after LP)/result before LP] × 
100. We defined clinical improvement as amelioration of at 
least 20% of at least one gait variable after LP. Patients were 
assessed for the presence of frontal and subcortical hypoki­
netic gait clinical features, according to definitions provided 
by Jankovic et al.11: slowness, abnormal postural adjustments, 
freezing, abnormal stance, disequilibrium, stiff trunk/legs, leg 
apraxia, improvement with cues, frontal signs, short stride, 
shuffling, narrow base, festination, start hesitation, turn en 
bloc, and Parkinsonian signs. 
All patients underwent brain MRI to confirm imagiolo­
gical criteria for NPH and to evaluate the presence of white 
matter ischemic lesions (WML). For subsequent analysis of 
WML, patients were classified according to the presence or 
absence of at least 1 lesion, irrespective of the region(s) affec­
ted. The MRI study was accompanied by the determination 
of CSF stroke volume in 20 patients. Values above 42 μl were 
considered to predict a favorable outcome12. Cerebrovascular 
risk factors (CVRF) were registered and defined as follows: 
1. arterial hypertension: documented history or treatment 
for hypertension, or blood pressure above 150 mmHg systolic 
or 90 mmHg diastolic on at least two occasions; 2. diabe­
tes mellitus: documented history or treatment for diabe­
tes mellitus or fasting glucose levels above 5.2 mmol/L; 3. 
hyperlipidemia: fasting triglyceride level above 1.6 mmol/L 
and/or fasting total cholesterol level above 200 mg/dL; 4. 
smoking habits: past or present use of tobacco; 5. cardiac 
diseases: documente d history or treatment for cardiac di­
sorders such as ischemic heart disease, cardiac insufficien­
cy, or atrial fibrillation; 6. previous stroke: documented his­
tory or treatment for transient ischemic attack or stroke; 
7. peripheral atherosclerosis: documented history of renal, 
aortic, iliac, limb, or retinal atherosclerosis. 
A qualitative grading of cognitive and gait dysfunction 
was performed at T0 and T1. 
Gait: 1. Normal; 2. Gait dysfunction as perceived by the 
patient, the clinician, or caretaker, but autonomous (no need 
for walking aid or help from another person); 3. Need of wal­
king aid; 4. Bedridden. 
Cognition: 1. Normal; 2. Cognitive dysfunction as percei­
ved by the patient, the clinician, or caretaker, but without cri­
teria for dementia (according to the DSM­IV definition); 3. 
Dementia according to the DSM­IV definition13. 
Patients were considered to have a favorable (as opposed 
to an unfavorable) outcome at T1 if they maintained normal 
status or improved dysfunctional status.
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Ethics
All patients signed informed consent forms, allowing the 
use of clinical data for scientific purposes. This study was ap­
proved by the local ethics committee (Comissão de Ética do 
Centro Hospitalar de Lisboa Ocidental).
statistical methods 
For statistical purposes, continuous variables were di­
chotomized. The relationship between cognitive and gait sta­
tus at follow­up and each variable at T0 was studied by chi­
square statistics, both globally and separately according to 
treatment (shunt Vs non­shunt). 
REsuLTs
We studied 35 patients, of which 21 were male. Mean 
age at T0 was 74.5±6.29 years. Age of onset was 71.7±6.86 
years. Time from T0 to T1 was 3.1±1.96 years (range, 1–9). 
Symptoms at T0 were gait (11), gait and cognition (6), gait 
and urinary incontinence (4), all (14). First symptom was 
gait (23), cognition (3), more than one symptom simulta­
neously (9). Gait at T0/T1 was graded as follows: normal 
function, 2/5; dysfunction but autonomous, 18/7; need of 
walking aid, 11/17; bedridden, 3/6. Cognition at T0/T1 was 
graded as follows: normal, 11/7; dysfunction, 12/11; demen­
tia, 11/17. 
Of the 35 patients examined, 13 received shunt surgery 
(which took place after T0 and before T1). Ten received a 
ventriculo­peritoneal shunt (7 with flux valves and 3 with 
programmable valves) and 3 underwent ventriculostomy. 
Nine additional patients were proposed for surgery but re­
fused. For statistical purposes, patients subjected to the dif­
ferent kinds of surgical procedures were evaluated as a sin­
gle group. 
Positive outcome in cognitive and gait function occurred in 
9 and 5 total (surgical and non­surgical) patients, respectively. 
Table 1 shows the comparison between patients with fa­
vorable and unfavorable gait function outcome. Younger age 
at onset, younger age at T0, and shunt surgery were signifi­
cant factors for patients with favorable outcome. CVRF and 
WML were significantly more frequent in patients with unfa­
vorable outcome. 
Positive outcome in cognition was associated with shunt 
surgery, but only at trend level (Table 2).  
In patients subjected to surgery, favorable outcome in 
motor function was also related to younger age at T0 and 
absen ce of CVRF. Absence of WML, younger age of onset, 
shorter duration, and shorter time between assessments 
were related to favorable outcome in gait disturbance after 
shunt surgery at trend level (0.05<p<0.1). In this group, cog­
nitive function outcome was not significantly related to any 
variable (Table 3). 
In terms of gait dysfunction, all patients not subjected to 
shunt surgery worsened or maintained disease status (de­
fined as unfavorable outcome). To better assess the natural 
history of NPH, we divided this group into those who main­
tained their previous status, even if not normal, and those 
with deteriorated motor status at T1. Longer time from T0 
to T1 was significantly associated with declining motor sta­
tus (p=0.012). WML were more frequent in patients who 
worsened, with a difference that almost reached significance 
(p=0.069). Cognitive dysfunction as measured by MMSE at 
T0 and/or T1 was significantly less frequent in patients who 
worsened (p=0.010).
Gait features, as defined by Jankovic et al., were not sig­
nificantly related to gait or cognitive outcome, either globally 
or in the surgery group (results not shown). 
WML, CVRF, and older age were not related to each other, 
according to chi­square analysis. 
Table 1. Gait outcome (global).
35 patients Favorable (n=5) Unfavorable (n=30) p-value
Age at T0 (<70 years) 5 2 <0.00001*****
Age of onset (<70 years) 5 7 0.002***
T0 to T1 (<3 years) 4 15 0.347
Duration (<3 years) 5 19 0.157
First symptom (gait Vs cognition) 3 19 1.000
Complete triad at T0 1 13 0.627
MMSE (normal Vs abnormal) (n=31, 4 Vs 27)a 3 11 0.304
CVRF (at least one Vs none) 1 25 0.010*
WML (at least one Vs none) 0 20 0.009**
Surgery 5 8 0.004***
Response to LP (n=31, 5 Vs 26)a 4 22 1.000
CSF stroke volume (>42 μg) (n=20, 3 Vs 17)a 2 15 0.404
Values represent number of patients. *****p<0.0005; ***p<0.005, **p<0.01, *p<0.05. aData for all variables were not available for all patients. Total n (n=…) 
and number of patients with positive Vs negative outcome (…Vs…) are indicated after each variable. n: number; CVRF: cerebrovascular risk factors; 
WML: white matter lesions; MMSE: Mini-Mental State Examination; CSF: cerebrospinal fluid; T0 and T1: time points at which outcome is assessed. 
893Paulo Bugalho et al. Normal pressure hydrocephalus: outcome
dIsCussIoN
NPH patient outcome was highly variable and differed in 
respect to cognitive and gait dysfunction.
Factors influencing gait dysfunction outcome
Patients with favorable gait outcome were all part of the 
surgical treatment group. Longer time between assessments 
was associated with increased gait dysfunction of non­ 
operated patients, which suggests that gait dysfunction is 
largely an irreversible condition that tends to worsen over 
time if not treated. Surgical treatment, however, was benefi­
cial for less than half of the patients, emphasizing the need 
for careful selection. Older age at time of assessment and 
the presence of CVRF were associated with unfavorable gait 
outcome for operated patients. The presence of WML was 
also significantly (p<0.05) associated with unfavorable out­
come globally, and at trend level (0.05<p<0.1) both on operated 
and not operated patients. Older age has been reported to be 
a ne ga tive prognostic factor in some14, but not all15 studies. 
The relationship between cerebrovascular disease and NPH 
has also been alluded to in previous work. Bugalho et al. 
demonstra ted an inverse relationship between the presence 
of WML and gait recovery after LP, suggesting that WML 
could preclude improvement after shunt surgery16. Other 
studies suggested that WML are factors for worse prognosis 
after shunt placement17. However, some authors have sug­
gested that WML should not contraindicate shunt surgery 
per se because some patients can benefit even if they have 
WML18. This premise is not corroborated by our study, in 
Table 2. Cognition outcome (global).
35 patients Favorable (n=9)
Unfavorable 
(n=26) p-value
Age (<70) 4 8 0.361
Age of onset (<70) 3 4 0.340
T0 to T1 (3< Vs >2 y) 5 14 0.619
Duration (<5 Vs >4 y) 3 17 0.129
First symptom (gait Vs cognition) 8 14 0.109
Complete triad at T0 1 12 0.262
MMSE (normal Vs abnormal) (n=31, 4 Vs 27)a 2 12 0.240
CVRF (at least one) 6 20 0.665
WML (at least one) 3 17 0.129
Surgery 6 7 0.050
Response to LP (n=31, 7 Vs 24)a 6 20 1.000
CSF stroke volume (>42 μg) (n=20, 5 Vs 15)a 5 12 0.539
Values represent number of patients. aData for all variables were not available for all patients. Total n (n=) and number of patients improved/non-improved 
(…Vs…) are indicated after of each variable. N: number; CVRF: cerebrovascular risk factors; WML: white matter lesions; MMSE: Mini-Mental State Examination; 
CSF: cerebrospinal fluid; T0 and T1: time points at which outcome is assessed.
















Age (<70) 5 1 0.005** 3 3 1.000
Age of onset (<70) 5 3 0.075 3 5 0.592
T0 to T1 (<3 years) 5 3 0.075 5 3 0.256
Duration (<5 years) 5 4 0.086 6 3 0.266
First symptom (gait) 3 7 0.580 6 4 0.559
Complete triad at T0 1 4 0.565 2 3 1.000
MMSE (below cut-off) (n=12) 3 2 0.222 2 3 1.000
CVRF (at least one Vs none) 1 7 0.032* 3 5 0.592
WML (at least one Vs none) 0 5 0.075 1 4 0.266
Response to LP (n=12) 4 7 0.417 4 7 0.417
CSF stroke volume (n=8)a 2 5 0.375 4 3 1.000
Values represent number of patients. **p<0.01; *p<0.05. aData for all variables were not available for all patients. Total n (n=) is indicated after each variable. 
CVRF: cerebrovascular risk factors; N: number; WML: white matter lesions; MMSE: Mini-Mental State Examination; CSF: cerebrospinal fluid; T0 and T1: time 
points at which outcome is assessed.
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which none of the patients with WML had a favorable gait 
outcome. Our results thus indicate that age and presence 
of WML and CVRF can predict worse gait outcome and 
should be weighed as negative factors in decisions regar­
ding surgical treatment.
CVRF, age, and WML were found to be significantly related, 
particularly in studies performed on leukoaraiosis patients19. 
We found no relation between these variables, either in ope­
rated or non­operated patients, which suggests that they 
independently influence NPH physiopathology by different 
mechanisms. Old age could associate with other comorbidi­
ties, such as cerebral degenerative changes or osteoarticular 
disease, neither of which would reverse with shunt surgery. 
Other studies have suggested that while WML can contri­
bute to symptoms by interrupting cognitive and gait path­
ways, CVRF, and arterial hypertension in particular, could act 
by increasing CSF pulsatility20. 
Factors influencing cognitive dysfunction outcome
Unlike gait outcome, cognitive outcome was not re­
lated to any factor except surgical treatment and only 
at trend level. This discrepancy may reflect the different 
pathophysiological mechanisms that produce gait and 
cognitive dysfunction. Also, with regard to the influence 
of WML, the location of lesions, not assessed in this study, 
may be more harmful to gait than to cognition. The wea­
ker response of cognitive than of gait dysfunction to shunt 
therapy, as reported in some papers21,22, could be caused 
by the superimposed effects of degenera tive changes on 
cognition­related structures, such as those of Alzheimer´s 
disease, which have been found in some studies to con­
tribute to NPH cognitive dysfunction and worse shunt 
outcome23. The higher frequency of cognitive dysfunction 
in patients whose gait did not worsen could also mean 
that cognitive and motor deterioration take divergent and 
possibly opposing pathways. Weaker association of co g­
ni tive function with shunt surgery could also be related 
to the presence in our study of non­shunted patients with 
positive outcome. These patients all maintained normal 
status, suggesting that progressive cognitive deterioration 
is not obligatory in NPH.
Factors not found to be related to outcome
Some factors found by other studies to be related to outcome 
did not show significant association with motor or co gnitive de­
cline in our study. A positive response to high volume LP has 
been considered a sign of reversibility of symptoms, which indi­
cates that the patient is only in the first stages of deterioration24 
and thus has a better chance of responding than do patients at 
later stages. In our study, however, motor outcome was not re­
lated to LP­induced improvement. Response to LP was also not 
significantly related to surgery outcome, which disagrees with 
studies that suggest that it is a good predictor of shunt out­
come24,25. In this respect, our results could have been biased by 
the common practice in our department not to propose shunt 
surgery to patients who did not respond to LP. In fact, only one 
patient proposed for shunt surgery had a negative LP result.
The relevance of increased CSF stroke volume to NPH as­
sessment is controversial. Preliminary studies suggest that 
hyperdinamic aqueductal flow is indicative of the reversibi­
lity of symptoms after shunt12. This relationship, however, 
was not observed consistently in subsequent studies26, and is 
not supported by our data. 
Other clinical variables found by some investigators to 
predict outcome include gait dysfunction as the primary 
symptom of the triad21, presence of the complete triad15, and 
duration of symptoms27­29. This was not the case in our study, 
although duration was related to gait outcome in operated 
patients at trend level. Specific gait symptoms were not related 
to the outcome, which disagrees with the suggestion that the 
presence of frontal release signs represents worse post­shunt 
prognosis, made by our group in a previous study30. 
Limitations
This study’s main limitation is that the time between assess­
ments ( from T0 to T1) is different between patients. However, 
we should say that this variable was included in the data analy­
sis, and did not appear to have a relevant influence on outcome. 
Also, the relatively small number of patients did not allow the 
use of statistics more powerful than chi­square, which does not 
permit multivariate analysis. Finally, patients were subjected to 
different surgical procedures (ventriculostomy, ventriculo­pe­
ritoneal shunt, etc), which could have biased outcome results. 
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